Chemoproteomics

Chemoproteomics is an approach to discovering mechanisms for regulating biological pathways for the purpose of designing new pharmaceutical therapies. It is a chemical proteomic method for pharmacological discovery research.

Introduction

Chemoproteomics can enable drug discovery.[1] It is a method for identifying protein targets and potential off-target activity.[2]

The science can be categorized into three categories: affinity pull-down, Capture Compound Mass Spectrometry and activity-based protein profiling.[3]

Method

A linker molecule connects a small molecule chemical probe (or library of chemical probes) with an analytically detectable bead or other agent for detection or separation.[4]

See also

References

  1. Raymond E. Moellering and Benjamin F. Cravatt* (2012). "How chemoproteomics can enable drug discovery and development". Chem Biol. 19 (1): 11–22. doi:10.1016/j.chembiol.2012.01.001.
  2. "Target Profiling of Drugs by Chemical Proteomics". Target Discovery Institute - TDI. Retrieved 4 Jan 2016.
  3. Marjeta Urh (2014). "Chemo Proteomics, a Valuable Tool for Biomarker and Drug Discovery". Molecular Biology. doi:10.4172/2168-9547.1000e117.
  4. Sonja Ghidelli-Disse1, Maria Jose Lafuente-Monasterio, David Waterson, Michael Witty, Yassir Younis, Tanya Paquet, Leslie J Street; et al. (2014). "Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics" (PDF). Malaria Journal. doi:10.1186/1475-2875-13-S1-P38.


This article is issued from Wikipedia - version of the Tuesday, February 16, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.